10 minute read
Aug. 21, 2023
Ansofaxine: An Active Prodrug, Triple Reuptake Inhibitor for Major Depressive Disorder
LY03005
oral serotonin-norepinephrine-dopamine reuptake inhibitor approved in China for major depressive disorder from serotinin-norepinephrine reuptake inhibitor, desvenlafaxine Transl. Psychiatry, May 10, 2023 Shandong Luye Pharmaceutical CO., CN
Loading...
